TapewireFind a company

person · Reporting owner

Deppe Michael J

Disclosed activity across 1 company

Tapewire entity
62370
SEC CIK
0001771759

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
QUEST DIAGNOSTICS INCDGX · Entity 2118SVP, Corp. Controller & CAOMarch 04, 2026March 06, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QUEST DIAGNOSTICS INC

Report date March 04, 2026 · Filed March 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect35,196 Ending reported balance After 2026-03-04 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-03-04 · Grant · Acquired 1,473 · Balance 35,946

F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Row 2 · 2026-03-04 · Tax withholding · Disposed 750 · Balance 35,196

F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Filing footnotes · ownership attribution and instrument terms

F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 04, 2026 Filed Mar 6, 2026 21:43 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 750 $204.86 $153,645.00
Disclosure

SEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 2

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,196

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:43 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,473 $204.86 $301,758.78
Disclosure

SEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 1

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,946

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 88 $204.86 $18,027.68
Disclosure

SEC source: 0001022079-26-000017 · wk-form4_1772660229.xml · nonDerivative · entry 1

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,473

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:09 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 1,688 $0.00 Strike: $204.96 $0.00
Disclosure

SEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · derivative · entry 5

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,688

Underlying: Common Stock · 1,688 shares

Expires 2036-02-18

F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:09 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 99 $206.99 $20,492.01
Disclosure

SEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 3

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,560

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:09 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 83 $210.01 $17,430.83
Disclosure

SEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 2

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,659

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:09 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 366 $0.00 $0.00
Disclosure

SEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 1

Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,742

F1 · security: Represents an award of restricted stock units.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 867 $173.74 $150,632.58
Disclosure

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,365

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,711 $173.74 $297,269.14
Disclosure

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,232

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 1,692 $173.74 $293,968.08
Disclosure

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,521

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 21:34 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 88 $171.75 $15,114.00
Disclosure

SEC source: 0001022079-25-000070 · wk-form4_1740778439.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,212

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:39 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 99 $169.71 $16,801.29
Disclosure

SEC source: 0001022079-25-000050 · wk-form4_1740173971.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,300

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 1,738 $0.00 Strike: $165.30 $0.00
Disclosure

SEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · derivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,738

Underlying: Common Stock · 1,738 shares

Expires 2035-02-12

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:26 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 454 $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,399

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: This amount includes previous exempt purchases made under the Company's stock purchase plan (the "plan") that were transferred out of the plan and into a brokerage account held by Reporting Person since the date of the last filing on Form 4.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 10,120 $66.51 Strike: $66.51 $673,081.20
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · derivative · entry 11

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,120 shares

Expires 2026-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 26, 2017, the second on February 25, 2018 and the final on February 25, 2019.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 8,635 $71.17 Strike: $71.17 $614,552.95
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · derivative · entry 10

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,635 shares

Expires 2025-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 5,189 $154.74 $802,958.31
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 8

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,941

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F6 · price: This transaction was executed in multiple trades at prices ranging from $154.460 - $155.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,331 $154.03 $359,046.26
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 7

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,130

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,600 $152.71 $397,049.90
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 6

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,461

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $152.400 to $153.170. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 4,135 $154.74 $639,833.36
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 5

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,061

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $154.460 to $155.180. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,400 $153.98 $369,558.96
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 4

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,196

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $153.460 - $154.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,100 $152.70 $320,676.09
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,596

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $152.400 to $153.200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 10,120 $66.51 $673,081.20
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
November 06, 2024 Filed Nov 7, 2024 22:21 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 8,635 $71.17 $614,552.95
Disclosure

SEC source: 0001022079-24-000204 · wk-form4_1731018097.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 21:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 57 $126.36 $7,202.52
Disclosure

SEC source: 0001022079-24-000078 · wk-form4_1709329341.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,930

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 21:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 52 $126.36 $6,570.72
Disclosure

SEC source: 0001022079-24-000078 · wk-form4_1709329341.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,987

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 21:31 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 631 $125.02 $78,887.62
Disclosure

SEC source: 0001022079-24-000062 · wk-form4_1709069467.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,039

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 21:31 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,689 $125.02 $211,158.78
Disclosure

SEC source: 0001022079-24-000062 · wk-form4_1709069467.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,670

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:31 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 89 $125.02 $11,126.78
Disclosure

SEC source: 0001022079-24-000049 · wk-form4_1708723821.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,981

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:01 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 2,322 $0.00 Strike: $127.81 $0.00
Disclosure

SEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · derivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,322

Underlying: Common Stock · 2,322 shares

Expires 2034-02-14

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:01 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 558 $0.00 $0.00
Disclosure

SEC source: 0001022079-24-000028 · wk-form4_1708131666.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,070

F1 · security: Represents an award of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 682 $147.86 $100,840.52
Disclosure

SEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,497

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 1,918 $147.86 $283,595.48
Disclosure

SEC source: 0001022079-23-000067 · wf-form4_167831132940620.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,178

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 68 $140.69 $9,566.92
Disclosure

SEC source: 0001022079-23-000046 · wf-form4_167787971519132.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,260

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:46 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 1,960 $0.00 Strike: $143.33 $0.00
Disclosure

SEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · derivative · entry 4

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,960

Underlying: Common Stock · 1,960 shares

Expires 2033-02-23

F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:46 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 498 $0.00 $0.00
Disclosure

SEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,328

F2 · security: Represents an award of restricted share units.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:46 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 188 $147.86 $27,797.68
Disclosure

SEC source: 0001022079-23-000033 · wf-form4_167753435928565.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,825

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
October 26, 2022 Filed Oct 27, 2022 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 6,371 $56.12 Strike: $56.12 $357,540.52
Disclosure

SEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · derivative · entry 6

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,371 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.

F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016.

Read SEC document
October 26, 2022 Filed Oct 27, 2022 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 9,126 $52.17 Strike: $52.17 $476,057.79
Disclosure

SEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · derivative · entry 5

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,126 shares

Expires 2024-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.

F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.

Read SEC document
October 26, 2022 Filed Oct 27, 2022 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 15,497 $145.00 $2,247,065.00
Disclosure

SEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,013

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
October 26, 2022 Filed Oct 27, 2022 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 6,371 $56.12 $357,540.52
Disclosure

SEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.

Read SEC document
October 26, 2022 Filed Oct 27, 2022 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 9,126 $52.17 $476,057.79
Disclosure

SEC source: 0001022079-22-000143 · wf-form4_166690650463923.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 12, 2022.

Read SEC document
May 18, 2022 Filed May 20, 2022 20:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 8 $136.98 $1,095.84
Disclosure

SEC source: 0001022079-22-000097 · wf-form4_165307945293358.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,006

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 21:58 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 79 $130.09 $10,277.11
Disclosure

SEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 4

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,011

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 21:58 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 206 $130.09 $26,798.54
Disclosure

SEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,089

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 07, 2022 Filed Mar 9, 2022 21:58 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 835 $130.09 $108,625.15
Disclosure

SEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,883

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 21:58 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 2,310 $130.09 $300,507.90
Disclosure

SEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,718

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
February 24, 2022 Filed Mar 1, 2022 00:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 2,654 $0.00 Strike: $127.73 $0.00
Disclosure

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · derivative · entry 4

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,654

Underlying: Common Stock · 2,654 shares

Expires 2032-02-24

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 00:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 3,132 $0.00 $0.00
Disclosure

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,408

F1 · security: Represents an award of restricted share units.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 00:42 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 549 $0.00 $0.00
Disclosure

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,276

F1 · security: Represents an award of restricted share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.